Initial Medication Adherence—Review and Recommendations for Good Practices in Outcomes Research: An ISPOR Medication Adherence and Persistence Special Interest Group Report
Abstract Background Positive associations between medication adherence and beneficial outcomes primarily come from studying filling/consumption behaviors after therapy initiation. Few studies have focused on what happens before initiation, the point from prescribing to dispensing of an initial presc...
Gespeichert in:
Veröffentlicht in: | Value in health 2015-07, Vol.18 (5), p.690-699 |
---|---|
Hauptverfasser: | , , , , , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
container_end_page | 699 |
---|---|
container_issue | 5 |
container_start_page | 690 |
container_title | Value in health |
container_volume | 18 |
creator | Hutchins, David S., MHSA, MBA Zeber, John E., MHA, PhD Roberts, Craig S., PharmD, MBA Williams, Allison F., RN, PhD Manias, Elizabeth, RN, BPharm, MPharm, PhD Peterson, Andrew M., PharmD, PhD |
description | Abstract Background Positive associations between medication adherence and beneficial outcomes primarily come from studying filling/consumption behaviors after therapy initiation. Few studies have focused on what happens before initiation, the point from prescribing to dispensing of an initial prescription. Objective Our objective was to provide guidance and encourage high-quality research on the relationship between beneficial outcomes and initial medication adherence (IMA), the rate initially prescribed medication is dispensed. Methods Using generic adherence terms, an international research panel identified IMA publications from 1966 to 2014. Their data sources were classified as to whether the primary source reflected the perspective of a prescriber, patient, or pharmacist or a combined perspective. Terminology and methodological differences were documented among core (essential elements of presented and unpresented prescribing events and claimed and unclaimed dispensing events regardless of setting), supplemental (refined for accuracy), and contextual (setting-specific) design parameters. Recommendations were made to encourage and guide future research. Results The 45 IMA studies identified used multiple terms for IMA and operationalized measurements differently. Primary data sources reflecting a prescriber’s and pharmacist’s perspective potentially misclassified core parameters more often with shorter/nonexistent pre- and postperiods (1–14 days) than did a combined perspective. Only a few studies addressed supplemental issues, and minimal contextual information was provided. Conclusions General recommendations are to use IMA as the standard nomenclature, rigorously identify all data sources, and delineate all design parameters. Specific methodological recommendations include providing convincing evidence that initial prescribing and dispensing events are identified, supplemental parameters incorporating perspective and substitution biases are addressed, and contextual parameters are included. |
doi_str_mv | 10.1016/j.jval.2015.02.015 |
format | Article |
fullrecord | <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_1706212706</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>S1098301515018446</els_id><sourcerecordid>1706212706</sourcerecordid><originalsourceid>FETCH-LOGICAL-c525t-1f3aaeb6718ffa2da04ddedd5e7e1544433a2e875c1d7cf29a549b82b5d835903</originalsourceid><addsrcrecordid>eNp9UkuOEzEQbSEQMwxcgAXykk03_rT7gxBSNIIQaVCiBNaWY1dr3HTbwXbPaHYcgnNwKE6COxlYIMTGVbbfey7Xqyx7TnBBMKle9UV_I4eCYsILTIsUHmTnhNMyL2vGHqYct03O0vlZ9iSEHmNcMcofZ2e0om2dLs-zHytropED-gjaKBmNs2ihr8GDVfDz2_ct3Bi4RdJqtAXlxhGsPqIC6pxHS-c02nipolEQkLFoPcUES_kWAkivrl-jhUWr3Wa9_ecbR-kN-GBCPO53B1BzQSsbEyJEtPRuOiS5g_Pxafaok0OAZ_fxIvv8_t2nyw_51Xq5ulxc5YpTHnPSMSlhX9Wk6TpJtcSl1qA1hxoIL8uSMUmhqbkiulYdbSUv231D91w3jLeYXWQvT7oH775OqQoxmqBgGKQFNwVBalxRQtOaoPQEVd6F4KETB29G6e8EwWL2SfRi9knMPglMRQqJ9OJef9qPoP9QfhuTAG9OAEi_TBZ4EZSZ-6ONBxWFdub_-m__oqvB2NT84QvcQejd5G3qnyAiJILYzZMyDwrhmDRlWbFfQfy81w</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>1706212706</pqid></control><display><type>article</type><title>Initial Medication Adherence—Review and Recommendations for Good Practices in Outcomes Research: An ISPOR Medication Adherence and Persistence Special Interest Group Report</title><source>MEDLINE</source><source>Elsevier ScienceDirect Journals</source><source>Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals</source><creator>Hutchins, David S., MHSA, MBA ; Zeber, John E., MHA, PhD ; Roberts, Craig S., PharmD, MBA ; Williams, Allison F., RN, PhD ; Manias, Elizabeth, RN, BPharm, MPharm, PhD ; Peterson, Andrew M., PharmD, PhD</creator><creatorcontrib>Hutchins, David S., MHSA, MBA ; Zeber, John E., MHA, PhD ; Roberts, Craig S., PharmD, MBA ; Williams, Allison F., RN, PhD ; Manias, Elizabeth, RN, BPharm, MPharm, PhD ; Peterson, Andrew M., PharmD, PhD ; IPSOR Medication Adherence and Persistence Special Interest Group</creatorcontrib><description>Abstract Background Positive associations between medication adherence and beneficial outcomes primarily come from studying filling/consumption behaviors after therapy initiation. Few studies have focused on what happens before initiation, the point from prescribing to dispensing of an initial prescription. Objective Our objective was to provide guidance and encourage high-quality research on the relationship between beneficial outcomes and initial medication adherence (IMA), the rate initially prescribed medication is dispensed. Methods Using generic adherence terms, an international research panel identified IMA publications from 1966 to 2014. Their data sources were classified as to whether the primary source reflected the perspective of a prescriber, patient, or pharmacist or a combined perspective. Terminology and methodological differences were documented among core (essential elements of presented and unpresented prescribing events and claimed and unclaimed dispensing events regardless of setting), supplemental (refined for accuracy), and contextual (setting-specific) design parameters. Recommendations were made to encourage and guide future research. Results The 45 IMA studies identified used multiple terms for IMA and operationalized measurements differently. Primary data sources reflecting a prescriber’s and pharmacist’s perspective potentially misclassified core parameters more often with shorter/nonexistent pre- and postperiods (1–14 days) than did a combined perspective. Only a few studies addressed supplemental issues, and minimal contextual information was provided. Conclusions General recommendations are to use IMA as the standard nomenclature, rigorously identify all data sources, and delineate all design parameters. Specific methodological recommendations include providing convincing evidence that initial prescribing and dispensing events are identified, supplemental parameters incorporating perspective and substitution biases are addressed, and contextual parameters are included.</description><identifier>ISSN: 1098-3015</identifier><identifier>EISSN: 1524-4733</identifier><identifier>DOI: 10.1016/j.jval.2015.02.015</identifier><identifier>PMID: 26297098</identifier><language>eng</language><publisher>United States: Elsevier Inc</publisher><subject>Consensus ; Drug Prescriptions - standards ; good research methodology ; Health Knowledge, Attitudes, Practice ; Humans ; initial compliance ; initial medication adherence ; Internal Medicine ; Medication Adherence ; Outcome Assessment (Health Care) - standards ; Pharmaceutical Services - standards ; Pharmacists - standards ; Practice Patterns, Physicians' - standards ; Research Design - standards ; Terminology as Topic</subject><ispartof>Value in health, 2015-07, Vol.18 (5), p.690-699</ispartof><rights>International Society for Pharmacoeconomics and Outcomes Research (ISPOR)</rights><rights>2015 International Society for Pharmacoeconomics and Outcomes Research (ISPOR)</rights><rights>Copyright © 2015 International Society for Pharmacoeconomics and Outcomes Research (ISPOR). Published by Elsevier Inc. All rights reserved.</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c525t-1f3aaeb6718ffa2da04ddedd5e7e1544433a2e875c1d7cf29a549b82b5d835903</citedby><cites>FETCH-LOGICAL-c525t-1f3aaeb6718ffa2da04ddedd5e7e1544433a2e875c1d7cf29a549b82b5d835903</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://www.sciencedirect.com/science/article/pii/S1098301515018446$$EHTML$$P50$$Gelsevier$$Hfree_for_read</linktohtml><link.rule.ids>314,776,780,3537,27901,27902,65306</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/26297098$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Hutchins, David S., MHSA, MBA</creatorcontrib><creatorcontrib>Zeber, John E., MHA, PhD</creatorcontrib><creatorcontrib>Roberts, Craig S., PharmD, MBA</creatorcontrib><creatorcontrib>Williams, Allison F., RN, PhD</creatorcontrib><creatorcontrib>Manias, Elizabeth, RN, BPharm, MPharm, PhD</creatorcontrib><creatorcontrib>Peterson, Andrew M., PharmD, PhD</creatorcontrib><creatorcontrib>IPSOR Medication Adherence and Persistence Special Interest Group</creatorcontrib><title>Initial Medication Adherence—Review and Recommendations for Good Practices in Outcomes Research: An ISPOR Medication Adherence and Persistence Special Interest Group Report</title><title>Value in health</title><addtitle>Value Health</addtitle><description>Abstract Background Positive associations between medication adherence and beneficial outcomes primarily come from studying filling/consumption behaviors after therapy initiation. Few studies have focused on what happens before initiation, the point from prescribing to dispensing of an initial prescription. Objective Our objective was to provide guidance and encourage high-quality research on the relationship between beneficial outcomes and initial medication adherence (IMA), the rate initially prescribed medication is dispensed. Methods Using generic adherence terms, an international research panel identified IMA publications from 1966 to 2014. Their data sources were classified as to whether the primary source reflected the perspective of a prescriber, patient, or pharmacist or a combined perspective. Terminology and methodological differences were documented among core (essential elements of presented and unpresented prescribing events and claimed and unclaimed dispensing events regardless of setting), supplemental (refined for accuracy), and contextual (setting-specific) design parameters. Recommendations were made to encourage and guide future research. Results The 45 IMA studies identified used multiple terms for IMA and operationalized measurements differently. Primary data sources reflecting a prescriber’s and pharmacist’s perspective potentially misclassified core parameters more often with shorter/nonexistent pre- and postperiods (1–14 days) than did a combined perspective. Only a few studies addressed supplemental issues, and minimal contextual information was provided. Conclusions General recommendations are to use IMA as the standard nomenclature, rigorously identify all data sources, and delineate all design parameters. Specific methodological recommendations include providing convincing evidence that initial prescribing and dispensing events are identified, supplemental parameters incorporating perspective and substitution biases are addressed, and contextual parameters are included.</description><subject>Consensus</subject><subject>Drug Prescriptions - standards</subject><subject>good research methodology</subject><subject>Health Knowledge, Attitudes, Practice</subject><subject>Humans</subject><subject>initial compliance</subject><subject>initial medication adherence</subject><subject>Internal Medicine</subject><subject>Medication Adherence</subject><subject>Outcome Assessment (Health Care) - standards</subject><subject>Pharmaceutical Services - standards</subject><subject>Pharmacists - standards</subject><subject>Practice Patterns, Physicians' - standards</subject><subject>Research Design - standards</subject><subject>Terminology as Topic</subject><issn>1098-3015</issn><issn>1524-4733</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2015</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNp9UkuOEzEQbSEQMwxcgAXykk03_rT7gxBSNIIQaVCiBNaWY1dr3HTbwXbPaHYcgnNwKE6COxlYIMTGVbbfey7Xqyx7TnBBMKle9UV_I4eCYsILTIsUHmTnhNMyL2vGHqYct03O0vlZ9iSEHmNcMcofZ2e0om2dLs-zHytropED-gjaKBmNs2ihr8GDVfDz2_ct3Bi4RdJqtAXlxhGsPqIC6pxHS-c02nipolEQkLFoPcUES_kWAkivrl-jhUWr3Wa9_ecbR-kN-GBCPO53B1BzQSsbEyJEtPRuOiS5g_Pxafaok0OAZ_fxIvv8_t2nyw_51Xq5ulxc5YpTHnPSMSlhX9Wk6TpJtcSl1qA1hxoIL8uSMUmhqbkiulYdbSUv231D91w3jLeYXWQvT7oH775OqQoxmqBgGKQFNwVBalxRQtOaoPQEVd6F4KETB29G6e8EwWL2SfRi9knMPglMRQqJ9OJef9qPoP9QfhuTAG9OAEi_TBZ4EZSZ-6ONBxWFdub_-m__oqvB2NT84QvcQejd5G3qnyAiJILYzZMyDwrhmDRlWbFfQfy81w</recordid><startdate>20150701</startdate><enddate>20150701</enddate><creator>Hutchins, David S., MHSA, MBA</creator><creator>Zeber, John E., MHA, PhD</creator><creator>Roberts, Craig S., PharmD, MBA</creator><creator>Williams, Allison F., RN, PhD</creator><creator>Manias, Elizabeth, RN, BPharm, MPharm, PhD</creator><creator>Peterson, Andrew M., PharmD, PhD</creator><general>Elsevier Inc</general><scope>6I.</scope><scope>AAFTH</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope></search><sort><creationdate>20150701</creationdate><title>Initial Medication Adherence—Review and Recommendations for Good Practices in Outcomes Research: An ISPOR Medication Adherence and Persistence Special Interest Group Report</title><author>Hutchins, David S., MHSA, MBA ; Zeber, John E., MHA, PhD ; Roberts, Craig S., PharmD, MBA ; Williams, Allison F., RN, PhD ; Manias, Elizabeth, RN, BPharm, MPharm, PhD ; Peterson, Andrew M., PharmD, PhD</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c525t-1f3aaeb6718ffa2da04ddedd5e7e1544433a2e875c1d7cf29a549b82b5d835903</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2015</creationdate><topic>Consensus</topic><topic>Drug Prescriptions - standards</topic><topic>good research methodology</topic><topic>Health Knowledge, Attitudes, Practice</topic><topic>Humans</topic><topic>initial compliance</topic><topic>initial medication adherence</topic><topic>Internal Medicine</topic><topic>Medication Adherence</topic><topic>Outcome Assessment (Health Care) - standards</topic><topic>Pharmaceutical Services - standards</topic><topic>Pharmacists - standards</topic><topic>Practice Patterns, Physicians' - standards</topic><topic>Research Design - standards</topic><topic>Terminology as Topic</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Hutchins, David S., MHSA, MBA</creatorcontrib><creatorcontrib>Zeber, John E., MHA, PhD</creatorcontrib><creatorcontrib>Roberts, Craig S., PharmD, MBA</creatorcontrib><creatorcontrib>Williams, Allison F., RN, PhD</creatorcontrib><creatorcontrib>Manias, Elizabeth, RN, BPharm, MPharm, PhD</creatorcontrib><creatorcontrib>Peterson, Andrew M., PharmD, PhD</creatorcontrib><creatorcontrib>IPSOR Medication Adherence and Persistence Special Interest Group</creatorcontrib><collection>ScienceDirect Open Access Titles</collection><collection>Elsevier:ScienceDirect:Open Access</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>Value in health</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Hutchins, David S., MHSA, MBA</au><au>Zeber, John E., MHA, PhD</au><au>Roberts, Craig S., PharmD, MBA</au><au>Williams, Allison F., RN, PhD</au><au>Manias, Elizabeth, RN, BPharm, MPharm, PhD</au><au>Peterson, Andrew M., PharmD, PhD</au><aucorp>IPSOR Medication Adherence and Persistence Special Interest Group</aucorp><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Initial Medication Adherence—Review and Recommendations for Good Practices in Outcomes Research: An ISPOR Medication Adherence and Persistence Special Interest Group Report</atitle><jtitle>Value in health</jtitle><addtitle>Value Health</addtitle><date>2015-07-01</date><risdate>2015</risdate><volume>18</volume><issue>5</issue><spage>690</spage><epage>699</epage><pages>690-699</pages><issn>1098-3015</issn><eissn>1524-4733</eissn><abstract>Abstract Background Positive associations between medication adherence and beneficial outcomes primarily come from studying filling/consumption behaviors after therapy initiation. Few studies have focused on what happens before initiation, the point from prescribing to dispensing of an initial prescription. Objective Our objective was to provide guidance and encourage high-quality research on the relationship between beneficial outcomes and initial medication adherence (IMA), the rate initially prescribed medication is dispensed. Methods Using generic adherence terms, an international research panel identified IMA publications from 1966 to 2014. Their data sources were classified as to whether the primary source reflected the perspective of a prescriber, patient, or pharmacist or a combined perspective. Terminology and methodological differences were documented among core (essential elements of presented and unpresented prescribing events and claimed and unclaimed dispensing events regardless of setting), supplemental (refined for accuracy), and contextual (setting-specific) design parameters. Recommendations were made to encourage and guide future research. Results The 45 IMA studies identified used multiple terms for IMA and operationalized measurements differently. Primary data sources reflecting a prescriber’s and pharmacist’s perspective potentially misclassified core parameters more often with shorter/nonexistent pre- and postperiods (1–14 days) than did a combined perspective. Only a few studies addressed supplemental issues, and minimal contextual information was provided. Conclusions General recommendations are to use IMA as the standard nomenclature, rigorously identify all data sources, and delineate all design parameters. Specific methodological recommendations include providing convincing evidence that initial prescribing and dispensing events are identified, supplemental parameters incorporating perspective and substitution biases are addressed, and contextual parameters are included.</abstract><cop>United States</cop><pub>Elsevier Inc</pub><pmid>26297098</pmid><doi>10.1016/j.jval.2015.02.015</doi><tpages>10</tpages><oa>free_for_read</oa></addata></record> |
fulltext | fulltext |
identifier | ISSN: 1098-3015 |
ispartof | Value in health, 2015-07, Vol.18 (5), p.690-699 |
issn | 1098-3015 1524-4733 |
language | eng |
recordid | cdi_proquest_miscellaneous_1706212706 |
source | MEDLINE; Elsevier ScienceDirect Journals; Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals |
subjects | Consensus Drug Prescriptions - standards good research methodology Health Knowledge, Attitudes, Practice Humans initial compliance initial medication adherence Internal Medicine Medication Adherence Outcome Assessment (Health Care) - standards Pharmaceutical Services - standards Pharmacists - standards Practice Patterns, Physicians' - standards Research Design - standards Terminology as Topic |
title | Initial Medication Adherence—Review and Recommendations for Good Practices in Outcomes Research: An ISPOR Medication Adherence and Persistence Special Interest Group Report |
url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-28T13%3A49%3A02IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Initial%20Medication%20Adherence%E2%80%94Review%20and%20Recommendations%20for%20Good%20Practices%20in%20Outcomes%20Research:%20An%20ISPOR%20Medication%20Adherence%20and%20Persistence%20Special%20Interest%20Group%20Report&rft.jtitle=Value%20in%20health&rft.au=Hutchins,%20David%20S.,%20MHSA,%20MBA&rft.aucorp=IPSOR%20Medication%20Adherence%20and%20Persistence%20Special%20Interest%20Group&rft.date=2015-07-01&rft.volume=18&rft.issue=5&rft.spage=690&rft.epage=699&rft.pages=690-699&rft.issn=1098-3015&rft.eissn=1524-4733&rft_id=info:doi/10.1016/j.jval.2015.02.015&rft_dat=%3Cproquest_cross%3E1706212706%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=1706212706&rft_id=info:pmid/26297098&rft_els_id=S1098301515018446&rfr_iscdi=true |